tiprankstipranks
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
US Market
DAWN
Day One Biopharmaceuticals
RESEARCH TOOLSreports
Want to see DAWN full AI Analyst Report?

Day One Biopharmaceuticals (DAWN) Financial Statements

462 Followers

Day One Biopharmaceuticals Financial Overview

Day One Biopharmaceuticals's market cap is currently $2.22B. The company's EPS TTM is $-0.21; its P/E ratio is -8.98; Day One Biopharmaceuticals is scheduled to report earnings on February 24, 2026, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 158.18M$ 131.16M$ 0.00$ 0.00$ 0.00
Gross Profit$ 140.97M$ 125.88M$ -383.00K$ -531.00K$ -199.00K
Operating Income$ -127.75M$ -217.27M$ -206.06M$ -146.91M$ -72.74M
EBITDA$ -105.82M$ -86.32M$ -188.53M$ -141.65M$ -72.56M
Net Income$ -107.32M$ -95.50M$ -188.92M$ -142.18M$ -70.64M
Balance Sheet
Cash & Short-Term Investments$ 441.11M$ 531.72M$ 366.35M$ 342.27M$ 284.31M
Total Assets$ 507.83M$ 582.79M$ 376.05M$ 349.06M$ 289.82M
Total Debt$ 2.79M$ 2.60M$ 408.00K$ 813.00K$ 220.00K
Net Debt$ -194.28M$ -122.37M$ -230.38M$ -84.45M$ -284.09M
Total Liabilities$ 66.67M$ 80.04M$ 29.51M$ 17.02M$ 8.67M
Stockholders' Equity$ 441.16M$ 502.75M$ 346.54M$ 332.04M$ 281.15M
Cash Flow
Free Cash Flow$ -104.08M$ -80.28M$ -150.08M$ -109.90M$ -56.54M
Operating Cash Flow$ -103.76M$ -78.11M$ -146.85M$ -109.87M$ -48.54M
Investing Cash Flow$ 174.65M$ -230.99M$ 128.38M$ -255.07M$ -8.00M
Financing Cash Flow$ 1.22M$ 203.29M$ 164.00M$ 165.90M$ 297.12M
Currency in USD

Day One Biopharmaceuticals Earnings and Revenue History

Income Statement >

Day One Biopharmaceuticals Debt to Assets

Balance Sheet >

Day One Biopharmaceuticals Cash Flow

Cash Flow >

Day One Biopharmaceuticals Forecast EPS vs Actual EPS

Earnings >